GO:0015966 diadenosine tetraphosphate biosynthetic process: Dinucleotide Signaling Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0015966 describes the biosynthetic process that produces diadenosine tetraphosphate (Ap4A), a dinucleoside polyphosphate involved in cellular stress responses and signaling.
• Ap4A is synthesized primarily by aminoacyl-tRNA synthetases, such as histidyl-tRNA synthetase, which catalyze the transfer of AMP to ATP.
• Ap4A levels are elevated in various organisms and tissues, including human myocardium, and are linked to apoptosis and quorum sensing.
• In Bacillus subtilis, Ap4A regulates GTP biosynthesis, highlighting its role in nucleotide homeostasis.
• Dysregulation of Ap4A metabolism is implicated in cancer, cardiovascular disease, and inflammatory conditions.
• CRISPR-based models (knockout, point mutation, knock-in, overexpression) enable precise dissection of Ap4A biosynthetic pathways and their physiological roles.
Description
Diadenosine tetraphosphate (Ap4A) is a dinucleoside polyphosphate composed of two adenosine moieties linked by four phosphate groups. The biosynthetic process that generates Ap4A is annotated as GO:0015966 (diadenosine tetraphosphate biosynthetic process) in the Gene Ontology. This process is conserved across prokaryotes and eukaryotes and is primarily catalyzed by aminoacyl-tRNA synthetases, which use ATP and AMP as substrates. Ap4A functions as a signaling molecule in stress responses, apoptosis, and bacterial quorum sensing. Understanding its biosynthesis is crucial for elucidating cellular nucleotide metabolism and its implications in human diseases such as cancer and cardiovascular disorders. Research into GO:0015966 has revealed that Ap4A levels are tightly regulated and can influence diverse pathways, including GTP biosynthesis in Bacillus subtilis. Moreover, Ap4A and its analogs have been detected in human tissues, including myocardial tissue, suggesting roles in cardiovascular physiology. The study of this process benefits from advanced molecular tools, including CRISPR gene editing, to manipulate key enzymes and dissect their contributions to Ap4A production and downstream effects.
diadenosine tetraphosphate biosynthetic process At A Glance
| GO ID | GO:0015966 |
|---|---|
| GO term | diadenosine tetraphosphate biosynthetic process |
| Ontology | biological_process |
| Synonym | diadenosine tetraphosphate anabolism, diadenosine tetraphosphate biosynthesis, diadenosine tetraphosphate formation, diadenosine tetraphosphate synthesis |
| Major function | Synthesis of diadenosine tetraphosphate (Ap4A), a signaling molecule involved in stress responses and nucleotide homeostasis |
| Key enzymes | Aminoacyl-tRNA synthetases (e.g., histidyl-tRNA synthetase), lysyl-tRNA synthetase |
| Substrates | ATP, AMP |
| Products | Diadenosine tetraphosphate (Ap4A) |
| Related processes | Ap4A degradation, purinergic signaling, apoptosis, quorum sensing |
What Is GO:0015966?
GO:0015966, diadenosine tetraphosphate biosynthetic process, is defined as the chemical reactions and pathways resulting in the formation of diadenosine tetraphosphate (Ap4A), a derivative of the nucleoside adenosine with four phosphate groups attached. This process encompasses the enzymatic synthesis of Ap4A from precursor molecules, typically ATP and AMP, and is a subset of dinucleoside polyphosphate metabolism.
Why Is diadenosine tetraphosphate biosynthetic process Important in Cell Biology?
The biosynthesis of diadenosine tetraphosphate (Ap4A) is important because Ap4A acts as a pleiotropic signaling molecule in both prokaryotic and eukaryotic cells. It is implicated in the cellular response to stress, including heat shock and oxidative stress, and can influence apoptosis and proliferation. In bacteria, Ap4A modulates quorum sensing and antibiotic responses. In humans, Ap4A has been detected in myocardial tissue and may play a role in cardiovascular function. Furthermore, Ap4A regulates GTP biosynthesis in Bacillus subtilis, linking it to nucleotide metabolism. Dysregulation of Ap4A levels has been associated with cancer and inflammatory diseases, making the enzymes involved in its biosynthesis potential therapeutic targets. Thus, understanding GO:0015966 provides insights into fundamental cellular processes and disease mechanisms.
• Ap4A is a conserved signaling molecule involved in stress responses and apoptosis.
• Biosynthesis of Ap4A is catalyzed by aminoacyl-tRNA synthetases, linking translation and nucleotide metabolism.
• Ap4A modulates bacterial quorum sensing and antibiotic susceptibility.
• In Bacillus subtilis, Ap4A regulates GTP biosynthesis, affecting nucleotide homeostasis.
• Ap4A is present in human myocardial tissue, suggesting roles in cardiovascular physiology.
• Dysregulation of Ap4A metabolism is implicated in cancer and inflammatory conditions.
• Ap4A and its analogs are potential biomarkers or therapeutic targets.
• Studying Ap4A biosynthesis aids in understanding purinergic signaling in ocular inflammation.
• Enzymes involved in Ap4A synthesis are conserved and can be targeted by CRISPR for functional studies.
• Ap4A degradation by specific hydrolases underscores the importance of balanced synthesis and breakdown.
What Happens During diadenosine tetraphosphate biosynthetic process?
Substrate Activation and Enzyme Binding
In simple terms: The building blocks ATP and AMP are recognized and bound by the enzyme.
The biosynthesis of diadenosine tetraphosphate (Ap4A) begins with the binding of substrates ATP and AMP to aminoacyl-tRNA synthetases, such as histidyl-tRNA synthetase. These enzymes typically activate amino acids for protein synthesis but can also catalyze the formation of Ap4A as a side reaction. The binding of ATP and AMP positions the substrates for nucleophilic attack, facilitating the transfer of AMP to ATP.
Catalytic Formation of Ap4A
In simple terms: The enzyme links AMP and ATP together to form Ap4A.
The catalytic mechanism involves the attack of the alpha-phosphate of ATP on the alpha-phosphate of AMP, resulting in the formation of a phosphoanhydride bond and release of pyrophosphate. This reaction is catalyzed by aminoacyl-tRNA synthetases, which can utilize either ATP and AMP directly or via an aminoacyl-adenylate intermediate. The resulting Ap4A is a dinucleoside tetraphosphate with two adenosine moieties linked by four phosphates.
Regulation of Ap4A Synthesis
In simple terms: The cell controls how much Ap4A is made.
Ap4A synthesis is regulated in response to cellular conditions. For example, in Bacillus subtilis, Ap4A levels are modulated by the availability of GTP, and Ap4A in turn regulates GTP biosynthesis, forming a feedback loop. In eukaryotic cells, Ap4A levels increase under stress conditions such as heat shock or oxidative stress, suggesting that its synthesis is part of a stress response. The activity of aminoacyl-tRNA synthetases can also be regulated by post-translational modifications and interacting proteins.
Degradation and Turnover
In simple terms: Ap4A is broken down to control its levels.
The steady-state level of Ap4A is determined by both synthesis and degradation. Specific hydrolases, such as dinucleoside polyphosphate hydrolases, cleave Ap4A into AMP and ATP or other products. In humans, two specific hydrolases selectively degrade 2'-adenylated Ap3A and Ap4A. This turnover ensures that Ap4A signals are transient and tightly controlled.
Integration with Cellular Metabolism
In simple terms: Ap4A connects to other metabolic pathways.
Ap4A biosynthesis is integrated with purine nucleotide metabolism and translation. In Bacillus subtilis, Ap4A regulates GTP biosynthesis by modulating the activity of enzymes involved in guanine nucleotide synthesis. In mammalian cells, Ap4A can influence purinergic signaling through interactions with purinergic receptors, as seen in ocular inflammation. Thus, Ap4A serves as a node linking translation, nucleotide metabolism, and signaling.
Key Genes Involved in GO:0015966 diadenosine tetraphosphate biosynthetic process
The following genes and proteins are key players in the biosynthesis and regulation of diadenosine tetraphosphate (Ap4A).
| Gene | Major Role | Research Relevance |
|---|---|---|
| HARS | Histidyl-tRNA synthetase; catalyzes Ap4A synthesis | Model enzyme for Ap4A biosynthesis; target for knockout studies |
| KARS | Lysyl-tRNA synthetase; can synthesize Ap4A | Alternative enzyme for Ap4A production; potential redundancy |
| DARS | Aspartyl-tRNA synthetase; may contribute to Ap4A synthesis | Less characterized; possible tissue-specific roles |
| AARS | Alanyl-tRNA synthetase; potential Ap4A synthase | Candidate for CRISPR screening |
| NUDT2 | Human dinucleoside polyphosphate hydrolase; degrades Ap4A | Regulates Ap4A turnover; knockout increases Ap4A |
| NUDT4 | Another human hydrolase; degrades Ap4A | Redundant with NUDT2; double knockout models |
| FHIT | Fragile histidine triad protein; involved in Ap3A/Ap4A metabolism | Tumor suppressor; links Ap4A to cancer |
| GTP biosynthesis genes (e.g., guaB) | Regulated by Ap4A in Bacillus subtilis | Model for Ap4A signaling in bacteria |
| P2Y receptors | Purinergic receptors; mediate Ap4A signaling | Implicated in ocular inflammation |
| P2X receptors | Purinergic receptors; may bind Ap4A | Potential mediators of Ap4A effects |
| Adenylate kinase | Maintains nucleotide balance; may influence Ap4A | Indirect role in Ap4A metabolism |
| ATP synthase | Produces ATP; substrate for Ap4A synthesis | Links energy metabolism to Ap4A |
| AMP deaminase | Regulates AMP levels; affects Ap4A synthesis | Modulates substrate availability |
| Purine nucleoside phosphorylase | Purine salvage; affects ATP/AMP pools | Indirect regulator of Ap4A |
| Hypoxanthine-guanine phosphoribosyltransferase (HPRT) | Purine salvage; affects nucleotide pools | Model for metabolic studies |
| Adenosine deaminase | Regulates adenosine levels; affects Ap4A | Potential modifier of Ap4A signaling |
| Casein kinase II | Phosphorylates aminoacyl-tRNA synthetases | May regulate Ap4A synthesis |
| Heat shock proteins (e.g., Hsp70) | Stress response; may interact with Ap4A pathway | Links stress to Ap4A |
How Is diadenosine tetraphosphate biosynthetic process Regulated?
The biosynthesis of diadenosine tetraphosphate (Ap4A) is regulated at multiple levels. In Bacillus subtilis, Ap4A levels are modulated by GTP availability, and Ap4A in turn regulates GTP biosynthesis, forming a feedback loop. In eukaryotic cells, Ap4A synthesis increases under stress conditions such as heat shock, oxidative stress, and apoptosis. The activity of aminoacyl-tRNA synthetases, the primary enzymes for Ap4A synthesis, can be regulated by post-translational modifications and interactions with other proteins. Additionally, the degradation of Ap4A by specific hydrolases such as NUDT2 and NUDT4 provides a means to rapidly adjust Ap4A levels. The balance between synthesis and degradation ensures that Ap4A acts as a transient signal. Furthermore, purinergic receptors may mediate downstream effects of Ap4A, as seen in ocular inflammation.
diadenosine tetraphosphate biosynthetic process and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| FHIT | Cancer (tumor suppressor) | Knockout in cancer cell lines; Ap4A level measurement |
| NUDT2 | Cancer, inflammatory diseases | Knockout mice; Ap4A accumulation studies |
| HARS | Cancer, neurodegeneration | Point mutation knock-in; Ap4A synthesis assays |
| P2Y receptors | Ocular inflammation | Overexpression in ocular cells; Ap4A treatment |
| GTP biosynthesis genes | Bacterial infections | Knockout in Bacillus subtilis; Ap4A regulation |
Cancer and Apoptosis
Diadenosine tetraphosphate (Ap4A) has been linked to apoptosis and cancer. In Fhit-positive HEK293 cells, intracellular Ap3A levels correlate with apoptosis, and Ap4A may play a similar role. The FHIT gene, which metabolizes Ap3A and Ap4A, is a tumor suppressor often lost in cancers. Dysregulation of Ap4A metabolism could contribute to tumorigenesis by affecting apoptosis and proliferation. Thus, enzymes involved in Ap4A biosynthesis are potential targets for cancer therapy.
Cardiovascular Disease
Ap4A, along with Ap5A and Ap6A, has been detected in human myocardial tissue, suggesting a role in cardiovascular physiology. These dinucleoside polyphosphates may influence vascular tone and cardiac function. Alterations in Ap4A levels could be associated with hypertension and other cardiovascular disorders. Studying Ap4A biosynthesis in myocardial tissue may reveal new therapeutic targets.
Inflammatory and Ocular Diseases
Purinergic receptors, which can be activated by Ap4A, are involved in ocular inflammation. Ap4A may act as a signaling molecule in inflammatory responses, and its biosynthesis could be upregulated in inflammatory conditions. Targeting Ap4A synthesis or its receptors might offer therapeutic benefits for inflammatory eye diseases.
Bacterial Infections and Quorum Sensing
In bacteria, Ap4A modulates quorum sensing, as shown in kanamycin-treated bacteria. Quorum sensing regulates virulence and antibiotic resistance. Therefore, Ap4A biosynthesis could be a target for novel antibacterial strategies. Understanding how Ap4A levels affect bacterial behavior may lead to new treatments for infections.
From diadenosine tetraphosphate biosynthetic process-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does HARS knockout reduce Ap4A levels? | CRISPR knockout of HARS in HEK293 cells |
| Does a point mutation in HARS affect Ap4A synthesis? | CRISPR point mutation knock-in of catalytic residue |
| Can Ap4A synthesis be tagged for live imaging? | Knock-in of fluorescent tag on HARS |
| Does overexpression of NUDT2 decrease Ap4A? | Overexpression of NUDT2 in mammalian cells |
| Does Ap4A regulate GTP biosynthesis? | Knockout of Ap4A synthase in Bacillus subtilis |
| Does Ap4A affect apoptosis? | Overexpression of Ap4A synthase in Fhit-positive cells |
How to Study the diadenosine tetraphosphate biosynthetic process Process
| Method | What It Measures | Typical Application |
|---|---|---|
| HPLC | Ap4A concentration | Quantification in tissues and cells |
| Mass spectrometry | Ap4A and related dinucleotides | Metabolomics profiling |
| Enzymatic assay | Ap4A synthesis activity | Kinetic studies of aminoacyl-tRNA synthetases |
| CRISPR screen | Genes regulating Ap4A levels | Discovery of novel pathway components |
| Fluorescent sensor imaging | Real-time Ap4A dynamics | Live-cell signaling studies |
| RNA-seq | Transcriptional changes upon Ap4A modulation | Pathway analysis |
| Proteomics | Protein interactions with Ap4A synthases | Identification of regulatory complexes |
| Ap4A degradation assay | Hydrolase activity | Study of NUDT enzymes |
Quantification of Ap4A Levels
Ap4A levels can be quantified using high-performance liquid chromatography (HPLC) or mass spectrometry. These methods allow precise measurement of Ap4A in cell extracts and tissues, as demonstrated in human myocardial tissue. Luciferase-based assays using Ap4A-specific enzymes can also be employed for high-throughput screening.
Enzymatic Assays for Ap4A Synthesis
In vitro enzymatic assays using purified aminoacyl-tRNA synthetases and radiolabeled ATP or AMP can measure Ap4A synthesis activity. These assays help determine kinetic parameters and identify inhibitors. Coupled assays with pyrophosphate detection are also useful.
CRISPR Screening for Ap4A Regulators
Genome-wide CRISPR knockout or activation screens can identify genes that regulate Ap4A levels. Cells are engineered to express an Ap4A-responsive reporter, and libraries are screened to find modifiers. This approach can uncover novel enzymes and pathways.
Imaging Ap4A Dynamics
Genetically encoded fluorescent sensors for Ap4A can be used to monitor real-time dynamics in live cells. These sensors typically consist of a Ap4A-binding domain fused to fluorescent proteins. Such tools enable spatial and temporal resolution of Ap4A signaling.
How CRISPR Can Be Used to Study GO:0015966 diadenosine tetraphosphate biosynthetic process
Knockout
CRISPR knockout of genes involved in Ap4A biosynthesis, such as HARS or KARS, can abolish or reduce Ap4A production. This allows researchers to study the consequences of Ap4A depletion on cellular stress responses, apoptosis, and metabolism. Knockout models are essential for establishing causality.
Point Mutation
Introducing point mutations in the catalytic domains of aminoacyl-tRNA synthetases can dissect their dual functions in translation and Ap4A synthesis. For example, mutations that impair Ap4A synthesis without affecting aminoacylation can reveal specific roles of Ap4A.
Knock-in
Knock-in of epitope tags or fluorescent proteins into endogenous Ap4A synthase genes enables visualization and affinity purification of the enzymes. This helps track their localization and interactions in real time.
Overexpression
Overexpression of Ap4A synthases or hydrolases can elevate or reduce Ap4A levels, respectively. This is useful for gain-of-function studies and for testing therapeutic hypotheses. For example, overexpressing NUDT2 can decrease Ap4A and assess its impact on cell survival.
How EDITGENE Supports diadenosine tetraphosphate biosynthetic process Research
Researchers studying diadenosine tetraphosphate biosynthetic process-related genes often need to determine whether a candidate gene is causally involved in Ap4A production, signaling, or downstream phenotypes. EDITGENE provides comprehensive CRISPR services to generate precisely engineered cell models, enabling rigorous functional validation.
Contact EDITGENE today to design your custom CRISPR model for diadenosine tetraphosphate biosynthetic process research.
Frequently Asked Questions About diadenosine tetraphosphate biosynthetic process
What is diadenosine tetraphosphate biosynthetic process?
It is the biological process (GO:0015966) that produces diadenosine tetraphosphate (Ap4A), a signaling molecule made from ATP and AMP by enzymes like aminoacyl-tRNA synthetases.
What genes are involved in diadenosine tetraphosphate biosynthetic process?
Key genes include HARS, KARS, DARS, and AARS, which encode aminoacyl-tRNA synthetases that catalyze Ap4A synthesis. Hydrolases like NUDT2 regulate Ap4A levels.
How is diadenosine tetraphosphate synthesized?
Ap4A is synthesized when an aminoacyl-tRNA synthetase transfers AMP from an aminoacyl-adenylate to ATP, forming a phosphoanhydride bond.
What is the role of Ap4A in cells?
Ap4A acts as a signaling molecule in stress responses, apoptosis, and bacterial quorum sensing. It also regulates GTP biosynthesis in Bacillus subtilis.
Is diadenosine tetraphosphate involved in disease?
Yes, Ap4A metabolism is linked to cancer, cardiovascular disease, and inflammation.
How can I study diadenosine tetraphosphate biosynthesis?
You can use CRISPR knockout, point mutation, knock-in, or overexpression models, combined with HPLC, mass spectrometry, and enzymatic assays.
What are the substrates for Ap4A synthesis?
The substrates are ATP and AMP, which are joined by a phosphoanhydride bond to form Ap4A.
Which enzymes degrade Ap4A?
Human NUDT2 and NUDT4 are hydrolases that selectively degrade Ap4A and related dinucleotides.
Does Ap4A have a role in bacteria?
Yes, Ap4A modulates quorum sensing in bacteria treated with kanamycin and regulates GTP biosynthesis in Bacillus subtilis.
What model systems are used to study Ap4A?
Common models include HEK293 cells, Bacillus subtilis, and human myocardial tissue, as well as CRISPR-engineered cell lines.
Conclusion
The diadenosine tetraphosphate biosynthetic process (GO:0015966) is a conserved pathway that produces Ap4A, a versatile signaling molecule involved in stress responses, apoptosis, and bacterial quorum sensing. Key enzymes include aminoacyl-tRNA synthetases such as HARS, while hydrolases like NUDT2 control turnover. Dysregulation of Ap4A metabolism has been linked to cancer, cardiovascular disease, and inflammation, making it a potential therapeutic target. Advances in CRISPR gene editing enable precise manipulation of Ap4A-related genes, facilitating functional studies and drug discovery. EDITGENE provides comprehensive CRISPR services to support research on this pathway.
References
- 1. Freist W et al.. 1999. Histidyl-tRNA synthetase.. Biol Chem 380(6):623-46 PMID: 10430027
- 2. Guranowski A et al.. 2000. Selective degradation of 2'-adenylated diadenosine tri- and tetraphosphates, Ap(3)A and Ap(4)A, by two specific human dinucleoside polyphosphate hydrolases.. Arch Biochem Biophys 373(1):218-24 PMID: 10620341
- 3. Guranowski A. 2003. Analogs of diadenosine tetraphosphate (Ap4A).. Acta Biochim Pol 50(4):947-72 PMID: 14739989
- 4. Fisher DI et al.. 2008. Correlation of intracellular diadenosine triphosphate (Ap3A) with apoptosis in Fhit-positive HEK293 cells.. Cancer Lett 259(2):186-91 PMID: 18006149
- 5. Ji X et al.. 2023. Diadenosine tetraphosphate modulated quorum sensing in bacteria treated with kanamycin.. BMC Microbiol 23(1):353 PMID: 37978430
- 6. Guzman-Aranguez A et al.. 2014. Purinergic receptors in ocular inflammation.. Mediators Inflamm 2014:320906 PMID: 25132732
- 7. Luo J et al.. 2004. Endogenous diadenosine tetraphosphate, diadenosine pentaphosphate, and diadenosine hexaphosphate in human myocardial tissue.. Hypertension 43(5):1055-9 PMID: 15066958
- 8. Giammarinaro PI et al.. 2022. Diadenosine tetraphosphate regulates biosynthesis of GTP in Bacillus subtilis.. Nat Microbiol 7(9):1442-1452 PMID: 35953658
